These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two help the concept of targeting ACKR3 as a unique method to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Diseases. A investigate review revealed in https://ellenl725gyv3.madmouseblog.com/profile